Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.

D. Posthouwer; K. Fischer; N. de Heusden; E.P. Mauser-Bunschoten

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.

Translated title of the contribution: Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.

D. Posthouwer, K. Fischer, N. de Heusden, E.P. Mauser-Bunschoten

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.
Original language	Undefined/Unknown
Pages (from-to)	98-103
Number of pages	6
Journal	Haemophilia
Volume	13
Publication status	Published - 2007

Cite this

@article{60f83d438fee42b7803a099cdbc829ca,

title = "Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience.",

author = "D. Posthouwer and K. Fischer and {de Heusden}, N. and E.P. Mauser-Bunschoten",

year = "2007",

language = "Undefined/Unknown",

volume = "13",

pages = "98--103",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "Wiley-Blackwell",

}